Efficacy and safety data in elderly patients with metastatic renal cell carcinoma included in the nivolumab Expanded Access Program (EAP) in Italy

BACKGROUND: Results from phase III clinical trial CheckMate 025 have established nivolumab as the standard of care for treatment of metastatic renal-cell carcinoma (mRCC) after VEGF inhibitor failure; however, elderly patients are under-represented in the registration trial and little is known about...

पूर्ण विवरण

ग्रंथसूची विवरण
मुख्य लेखकों: Vitale, Maria Giuseppa, Scagliarini, Sarah, Galli, Luca, Pignata, Sandro, Lo Re, Giovanni, Berruti, Alfredo, Defferrari, Carlotta, Spada, Massimiliano, Masini, Cristina, Santini, Daniele, Ciuffreda, Libero, Ruggeri, Enzo Maria, Bengala, Carmelo, Livi, Lorenzo, Fagnani, Daniele, Bonetti, Andrea, Giustini, Lucio, Hamzaj, Alketa, Procopio, Giuseppe, Caserta, Claudia, Sabbatini, Roberto
स्वरूप: Online लेख मूलपाठ
भाषा:English
प्रकाशित: Public Library of Science 2018
विषय:
Research Article
ऑनलाइन पहुंच:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6034807/
https://www.ncbi.nlm.nih.gov/pubmed/29979712
http://dx.doi.org/10.1371/journal.pone.0199642

इंटरनेट

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6034807/
https://www.ncbi.nlm.nih.gov/pubmed/29979712
http://dx.doi.org/10.1371/journal.pone.0199642

समान संसाधन